Kenya says it will move ahead with AstraZeneca COVID-19 vaccine (Adds details) NAIROBI, Feb 11 (Reuters) – Kenya is going ahead with its plan to inoculate its citizens against COVID-19 using a vaccine developed by AstraZeneca, a senior health ministry official said on Thursday, dismissing concerns over its efficacy.South Africa paused the rollout of the vaccine developed by AstraZeneca and Oxford University following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 variant dominant in the country.That move will not deter Kenya, which says it expects to receive 24 million doses of the vaccine beginning this month, said Mercy Mwangangi, the chief administrative secretary at the ministry.”We are going to continue with AstraZeneca because we are doing our own sequencing and we are comfortable to move forward with it,” she told Reuters.The World Heath Organisation had also issued an advisory on Wednesday telling countries to continue using the vaccine, Mwangangi said, which further supports the Kenyan government’s position.(Reporting by Duncan Miriri, Editing by William Maclean) First Published: 2021-02-11 11:13:27 Updated 2021-02-11 11:30:15
© 2021 Thomson Reuters.
All rights reserved.Reuters content is the intellectual property of Thomson Reuters or its third party content providers.Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon.”Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.Most read today What is RSS? » Risk Disclosure: Sharenet will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals.
Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.Currency trading on margin involves high risk, and is not suitable for all investors.Trading or investing in crypto currencies carries with it potential risks.Prices of crypto currencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events.Crypto currencies are not suitable for all investors.Before deciding to trade foreign exchange or any other financial instrument or crypto currencies you should carefully consider your investment objectives, level of experience, and risk appetite.
Sharenet would like to remind you that the data contained in this website is not necessarily real-time nor accurate.All CFDs (stocks, indexes, futures), Forex and crypto currencies prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes.Therefore Sharenet doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.
Sharenet may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.Market Statistics are calculated by Sharenet and are therefore not the official JSE Market Statistics.The calculation/derivation may include underlying JSE data.
Sharenet Group of Companies are authorised financial services providers.Sharenet Securities FSP#: 28430 | Sharenet Wealth FSP#: 41688 © 2021 SHARENET (PTY) Ltd, Cape Town, South Africa.
